These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 6364297
21. Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma. Willey RF, Godden DJ, Carmichael J, Preston P, Frame MH, Crompton GK. Eur J Respir Dis Suppl; 1982; 122():138-42. PubMed ID: 6958478 [Abstract] [Full Text] [Related]
22. Beclomethasone dipropionate aerosol in allergic rhinitis. Cockcroft DW, MacCormack DW, Newhouse MT, Hargreave FE. Can Med Assoc J; 1976 Sep 18; 115(6):523-6. PubMed ID: 782679 [Abstract] [Full Text] [Related]
23. Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Tjwa MK. Ann Allergy Asthma Immunol; 1995 Aug 18; 75(2):107-11. PubMed ID: 7648372 [Abstract] [Full Text] [Related]
30. [Budesonide (Turbuhaler) at a dosage of 400 micrograms per day is at least as effective as a double dose of beclomethasone (MDI) in patients with mild to moderately severe bronchial asthma]. Vondra V, Kraszkó P, Malolepszy J. Cas Lek Cesk; 1999 Jan 25; 138(3):78-81. PubMed ID: 10376390 [Abstract] [Full Text] [Related]
31. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected. Kita H, Jorgensen RK, Reed CE, Dunnette SL, Swanson MC, Bartemes KR, Squillace D, Blomgren J, Bachman K, Gleich GJ. J Allergy Clin Immunol; 2000 Sep 25; 106(3):521-9. PubMed ID: 10984373 [Abstract] [Full Text] [Related]
33. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma. Ige OM, Sogaolu OM. Afr J Med Med Sci; 2004 Jun 25; 33(2):155-60. PubMed ID: 15565935 [Abstract] [Full Text] [Related]
34. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis. Adamopoulos G, Manolopoulos L, Giotakis I. Clin Otolaryngol Allied Sci; 1995 Aug 25; 20(4):340-4. PubMed ID: 8548967 [Abstract] [Full Text] [Related]
35. A multicentre study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitis. Haye R, Gomez EG. Rhinology; 1993 Dec 25; 31(4):169-74. PubMed ID: 8140383 [Abstract] [Full Text] [Related]
36. A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis. Munch EP, Søborg M, Nørreslet TT, Mygind N. Allergy; 1983 Oct 25; 38(7):517-24. PubMed ID: 6139040 [Abstract] [Full Text] [Related]
37. Intranasal budesonide for allergic rhinitis. Med Lett Drugs Ther; 1994 Jul 08; 36(926):63-4. PubMed ID: 8015513 [No Abstract] [Full Text] [Related]
38. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Mygind N. Br Med J; 1973 Nov 24; 4(5890):464-6. PubMed ID: 4586044 [Abstract] [Full Text] [Related]